Zobrazeno 1 - 10
of 983
pro vyhledávání: '"Clavero, O."'
Autor:
Nibu KI; Department of Otolaryngology-Head and Neck Surgery, Kobe University, Graduate School of Medicine, Kobe, Hyogo, Japan., Oridate N; Department of Otolaryngology, Head and Neck Surgery, School of Medicine, Yokohama City University, Yokohama, Kanagawa, Japan., Saito Y; Department of Otolaryngology, Head and Neck Surgery, University of Tokyo, Tokyo, Japan., Roset M; IQVIA, Barcelona, Spain., Forés Maresma M; IQVIA, Barcelona, Spain., Cuadras D; IQVIA, Barcelona, Spain., Morais E; MSD France, Puteaux, France., Roberts C; Merck & Co., Inc., Rahway, New Jersey, USA., Chen YT; Merck & Co., Inc., Rahway, New Jersey, USA., Spitzer J; Merck & Co., Inc., Rahway, New Jersey, USA., Sato K; MSD K.K., Tokyo, Japan., Saito I; MSD K.K., Tokyo, Japan., Tazaki I; MSD K.K., Tokyo, Japan., Clavero O; Cancer Epidemiology Research Program, Catalan Institute of Oncology, IDIBELL, EPIBELL, Barcelona, Spain.; Centro de Investigación Biomédica en Red: Epidemiología y Salud Pública (CIBERESP), Instituto de Salud Carlos III, Madrid, Spain., Schroeder L; German Cancer Research Center (DKFZ), Heidelberg, Germany., Alemany L; Cancer Epidemiology Research Program, Catalan Institute of Oncology, IDIBELL, EPIBELL, Barcelona, Spain.; Centro de Investigación Biomédica en Red: Epidemiología y Salud Pública (CIBERESP), Instituto de Salud Carlos III, Madrid, Spain., Mehanna H; Institute of Head & Neck Studies and Education (InHANSE), University of Birmingham, Birmingham, UK., Mirghani H; Department of Oto-Rhino-Laryngology and Head and Neck Surgery, Hôpital Européen Georges Pompidou, APHP, Université Paris-Cité, Paris, France., Giuliano AR; Center for Immunization and Infection Research in Cancer, Moffitt Cancer Center and Research Institute, Tampa, Florida, USA., Pavón MA; Cancer Epidemiology Research Program, Catalan Institute of Oncology, IDIBELL, EPIBELL, Barcelona, Spain.; Centro de Investigación Biomédica en Red: Epidemiología y Salud Pública (CIBERESP), Instituto de Salud Carlos III, Madrid, Spain., Waterboer T; German Cancer Research Center (DKFZ), Heidelberg, Germany.
Publikováno v:
Cancer science [Cancer Sci] 2024 Aug; Vol. 115 (8), pp. 2808-2818. Date of Electronic Publication: 2024 Jun 07.
Autor:
Sanchez DF; Instituto de Patología e Investigación, Asunción 1228, Paraguay; Translational Oncogenomics Group, Cancer Research UK Manchester Institute, University of Manchester, Manchester Cancer Research Centre, Manchester M20 4GJ, UK., Fernández-Nestosa MJ; Universidad Nacional de Asunción, San Lorenzo 2111, Paraguay., Alemany L; Institut Català D'Oncologia, Barcelona 08908, Spain., Cañete-Portillo S; University of Alabama, Birmingham, AL 35233, USA., Lloveras B; Hospital Del Mar, Barcelona 08003, Spain., Clavero O; Institut Català D'Oncologia, Barcelona 08908, Spain., Rodríguez I; Instituto de Patología e Investigación, Asunción 1228, Paraguay; Universidad Nacional de Asunción, San Lorenzo 2111, Paraguay., Quint W; DDL Diagnostic Laboratory, Rijswijk 2288, Netherlands., Muñoz N; National Cancer Institute of Colombia, Bogotá 111511-110411001, Colombia., de Sanjosé S; Barcelona Institute for Global Health (ISGlobal), Barcelona 08036, Spain., Bosch FX; Institut Català D'Oncologia, Barcelona 08908, Spain., Cubilla AL; Instituto de Patología e Investigación, Asunción 1228, Paraguay; Universidad Nacional de Asunción, San Lorenzo 2111, Paraguay. Electronic address: antoniocubillaramos@gmail.com.
Publikováno v:
Human pathology [Hum Pathol] 2023 Sep; Vol. 139, pp. 65-72. Date of Electronic Publication: 2023 Jul 08.
Autor:
Mena, M, Wang, X, Tous, S, Quiros, B, Clavero, O, Alejo, M, Morey, F, Taberna, M, Vintro, XL, Rubio, BL, Alos, L, Mehanna, H, Quint, W, Pawlita, M, Tommasino, M, Pavon, MA, Munoz, N, De Sanjose, S, Bosch, FX, Alemany, L
Publikováno v:
Cancers
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
Simple Summary The utility of a diagnostic algorithm for the detection of HPV-driven oral cavity (OCC), oropharyngeal (OPC), and laryngeal (LC) carcinomas using HPV-DNA testing followed by p16(INK4a) immunohistochemistry, taking E6*I mRNA detection a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=RECOLECTA___::d69f197bd0647a1776108b3e5008aeae
https://iibsantpau.fundanetsuite.com/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=12269
https://iibsantpau.fundanetsuite.com/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=12269
Autor:
Rakislova N; Department of Pathology, Barcelona Institute of Global Health (ISGlobal), Hospital Clínic-University of Barcelona., Alemany L; Public Research Consortium of Epidemiology and Public Health (CIBER).; Unit of Infections and Cancer, Cancer Epidemiology Research Program, Catalan Institute of Oncology, IDIBELL., Clavero O; Public Research Consortium of Epidemiology and Public Health (CIBER).; Unit of Infections and Cancer, Cancer Epidemiology Research Program, Catalan Institute of Oncology, IDIBELL., Del Pino M; Institute of Gynecology, Obstetrics and Neonatology, Hospital Clínic, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Faculty of Medicine, University of Barcelona., Saco A; Department of Pathology, Barcelona Institute of Global Health (ISGlobal), Hospital Clínic-University of Barcelona., Marimon L; Department of Pathology, Barcelona Institute of Global Health (ISGlobal), Hospital Clínic-University of Barcelona., Quirós B; Public Research Consortium of Epidemiology and Public Health (CIBER).; Unit of Infections and Cancer, Cancer Epidemiology Research Program, Catalan Institute of Oncology, IDIBELL., Lloveras B; Department of Pathology, Hospital Mar, Barcelona., Ribera-Cortada I; Department of Pathology, Barcelona Institute of Global Health (ISGlobal), Hospital Clínic-University of Barcelona., Alejo M; Department of Pathology, General Hospital of Hospitalet, L'Hospitalet de Llobregat, Spain., Pawlita M; Division of Molecular Diagnostics of Oncogenic Infections, Research Program Infection, Inflammation and Cancer, German Cancer Research Center (DKFZ), Heidelberg, Germany., Quint W; DDL Diagnostic Laboratory, Rijswijk, The Netherlands., de Sanjose S; Public Research Consortium of Epidemiology and Public Health (CIBER).; Unit of Infections and Cancer, Cancer Epidemiology Research Program, Catalan Institute of Oncology, IDIBELL., Ordi J; Department of Pathology, Barcelona Institute of Global Health (ISGlobal), Hospital Clínic-University of Barcelona.; Public Research Consortium of Epidemiology and Public Health (CIBER).
Publikováno v:
The American journal of surgical pathology [Am J Surg Pathol] 2020 Nov; Vol. 44 (11), pp. 1506-1514.
Autor:
Pimenoff, V.N., Félez-Sánchez, M., Tous, S., Clavero, O., Godínez, J.M., Klaustermeier, J., Saunier, M., Molijn, A., Alemany, L., Quint, W., Bosch, F.X., de Sanjosé, S., McCloskey, J., Bravo, I.G.
Publikováno v:
In Clinical Microbiology and Infection June 2015 21(6):605-605
Autor:
Fernández-Nestosa MJ; Facultad Politécnica, Universidad Nacional de Asunción, San Lorenzo, 2111, Paraguay., Clavero O; Institut Català D'Oncologia, Barcelona, 08908, Spain., Sánchez DF; Facultad de Ciencias Médicas, Universidad Nacional de Asunción, San Lorenzo, 2111, Paraguay; Instituto de Patología e Investigación, Asunción, 1228, Paraguay., Giannico GA; Department of Pathology, Microbiology and Immunology, Vanderbilt University Medical Center, Nashville, TN, 37212, USA., Lobatti A; Facultad Politécnica, Universidad Nacional de Asunción, San Lorenzo, 2111, Paraguay., Cañete-Portillo S; Department of Pathology, University of Alabama at Birmingham, Birmingham, AL, 35233, USA., Velázquez EF; Massachusetts General Hospital and Harvard Medical School, Boston, MA, 02115, USA., Alemany L; Institut Català D'Oncologia, Barcelona, 08908, Spain; CIBER en Epidemiología y Salud Pública (CIBERESP), Barcelona, 08023, Spain., Muñoz N; National Cancer Institute of Colombia, Bogotá, 111511-110411001, Colombia., de San José S; Institut Català D'Oncologia, Barcelona, 08908, Spain; CIBER en Epidemiología y Salud Pública (CIBERESP), Barcelona, 08023, Spain., Bosch FX; Institut Català D'Oncologia, Barcelona, 08908, Spain., Cubilla AL; Facultad de Ciencias Médicas, Universidad Nacional de Asunción, San Lorenzo, 2111, Paraguay; Instituto de Patología e Investigación, Asunción, 1228, Paraguay. Electronic address: antoniocubilla@ipi.com.py.
Publikováno v:
Human pathology [Hum Pathol] 2023 Jan; Vol. 131, pp. 1-8. Date of Electronic Publication: 2022 Nov 24.
Autor:
Mena, M., Frias-Gomez, J., Taberna, M., Quirós, B., Marquez, S., Clavero, O., Baena, A., Lloveras, B., Alejo, M., León, X., García, J., Mesía, R., Bermejo, O., Bonfill, T., Aguila, A., Guix, M., Hijano, R., Pavón, M. A., Torres, M., Tous, S.
Publikováno v:
Scientific Reports; 8/6/2020, Vol. 10 Issue 1, p1-11, 11p
Autor:
Mena M; Cancer Epidemiology Research Program, Catalan Institute of Oncology (ICO)-IDIBELL, L'Hospitalet de Llobregat, 08908 Barcelona, Spain.; Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), Instituto de Salud Carlos III, 28029 Madrid, Spain., Wang X; Cancer Epidemiology Research Program, Catalan Institute of Oncology (ICO)-IDIBELL, L'Hospitalet de Llobregat, 08908 Barcelona, Spain., Tous S; Cancer Epidemiology Research Program, Catalan Institute of Oncology (ICO)-IDIBELL, L'Hospitalet de Llobregat, 08908 Barcelona, Spain.; Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), Instituto de Salud Carlos III, 28029 Madrid, Spain., Quiros B; Cancer Epidemiology Research Program, Catalan Institute of Oncology (ICO)-IDIBELL, L'Hospitalet de Llobregat, 08908 Barcelona, Spain.; Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), Instituto de Salud Carlos III, 28029 Madrid, Spain., Clavero O; Cancer Epidemiology Research Program, Catalan Institute of Oncology (ICO)-IDIBELL, L'Hospitalet de Llobregat, 08908 Barcelona, Spain.; Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), Instituto de Salud Carlos III, 28029 Madrid, Spain., Alejo M; Pathology Department, Hospital de Vic, 08500 Vic, Spain.; Pathology Department, Hospital General de l'Hopitalet, L'Hospitalet de Llobregat, 08908 Barcelona, Spain., Morey F; Cancer Epidemiology Research Program, Catalan Institute of Oncology (ICO)-IDIBELL, L'Hospitalet de Llobregat, 08908 Barcelona, Spain., Taberna M; Oncology Department, Catalan Institute of Oncology (ICO)-IDIBELL, ONCOBELL, L'Hospitalet de Llobregat, 08908 Barcelona, Spain., Leon Vintro X; Otorhinolaryngology Department, Hospital Sant Pau, 08026 Barcelona, Spain.; Centro de Investigación Biomédica en Red de Bioingeniería, Biomateriales y Nanomedicina (CIBER-BBN), Instituto de Salud Carlos III, 28029 Madrid, Spain., Lloveras Rubio B; Pathology Department, Hospital del Mar, 08003 Barcelona, Spain., Alos L; Pathology Department, Hospital Clinic, 08036 Barcelona, Spain., Mehanna H; Institute of Head and Neck Studies and Education, University of Birmingham, Birmingham B15 2TT, UK., Quint W; DDL Diagnostic Laboratory, 2288 ER Rijswijk, The Netherlands., Pawlita M; Division of Molecular Diagnostics of Oncogenic Infections, Research Program Infection, Inflammation and Cancer, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany., Tommasino M; Infections and Cancer Biology Group, International Agency for Research on Cancer (IARC), 69372 Lyon, France., Pavón MA; Cancer Epidemiology Research Program, Catalan Institute of Oncology (ICO)-IDIBELL, L'Hospitalet de Llobregat, 08908 Barcelona, Spain.; Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), Instituto de Salud Carlos III, 28029 Madrid, Spain., Muñoz N; National Cancer Institute, Bogotá 111511, Colombia., De Sanjose S; Cancer Epidemiology Research Program, Catalan Institute of Oncology (ICO)-IDIBELL, L'Hospitalet de Llobregat, 08908 Barcelona, Spain.; Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), Instituto de Salud Carlos III, 28029 Madrid, Spain.; ISGlobal, 08036 Barcelona, Spain., Bosch FX; Cancer Epidemiology Research Program, Catalan Institute of Oncology (ICO)-IDIBELL, L'Hospitalet de Llobregat, 08908 Barcelona, Spain.; Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), Instituto de Salud Carlos III, 28029 Madrid, Spain.; Universitat Oberta de Catalunya, 08035 Barcelona, Spain., Alemany L; Cancer Epidemiology Research Program, Catalan Institute of Oncology (ICO)-IDIBELL, L'Hospitalet de Llobregat, 08908 Barcelona, Spain.; Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), Instituto de Salud Carlos III, 28029 Madrid, Spain., On Behalf Of The Ico International Hpv In Head And Neck Cancer Study Group
Publikováno v:
Cancers [Cancers (Basel)] 2022 Aug 04; Vol. 14 (15). Date of Electronic Publication: 2022 Aug 04.
Autor:
Fulla M; Department of Otorhinolaryngology, Hospital Universitari Bellvitge, L'Hospitalet de Llobregat, Barcelona, Spain. mfulla@bellvitgehospital.cat.; Program of Molecular Mechanisms and Experimental Therapy in Oncology, Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, Barcelona, Spain. mfulla@bellvitgehospital.cat., Szafarowski T; Department of Otorhinolaryngology, Faculty of Medicine and Dentistry, Medical University of Warsaw, Warsaw, Poland., Frias-Gomez J; Cancer Epidemiology Research Program, Catalan Institute of Oncology (ICO) - L'Hospitalet de Llobregat, Barcelona, Spain.; Epidemiology, Public Health, Cancer Prevention and Palliative Care Program, IDIBELL, L'Hospitalet de Llobregat, Barcelona, Spain., Quiros B; Cancer Epidemiology Research Program, Catalan Institute of Oncology (ICO) - L'Hospitalet de Llobregat, Barcelona, Spain.; Epidemiology, Public Health, Cancer Prevention and Palliative Care Program, IDIBELL, L'Hospitalet de Llobregat, Barcelona, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Instituto de Salud Carlos III, Madrid, Spain., Clavero O; Cancer Epidemiology Research Program, Catalan Institute of Oncology (ICO) - L'Hospitalet de Llobregat, Barcelona, Spain.; Epidemiology, Public Health, Cancer Prevention and Palliative Care Program, IDIBELL, L'Hospitalet de Llobregat, Barcelona, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Instituto de Salud Carlos III, Madrid, Spain., Gomà M; Program of Molecular Mechanisms and Experimental Therapy in Oncology, Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, Barcelona, Spain.; Department of Pathology, Hospital Universitari Bellvitge, L'Hospitalet de Llobregat, Barcelona, Spain., Pavon MA; Cancer Epidemiology Research Program, Catalan Institute of Oncology (ICO) - L'Hospitalet de Llobregat, Barcelona, Spain.; Epidemiology, Public Health, Cancer Prevention and Palliative Care Program, IDIBELL, L'Hospitalet de Llobregat, Barcelona, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Instituto de Salud Carlos III, Madrid, Spain., Jurek-Matusiak O; Department of Otorhinolaryngology, Faculty of Medicine and Dentistry, Medical University of Warsaw, Warsaw, Poland., Lares HR; Department of Otorhinolaryngology, Hospital Universitari Bellvitge, L'Hospitalet de Llobregat, Barcelona, Spain.; Program of Molecular Mechanisms and Experimental Therapy in Oncology, Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, Barcelona, Spain., Mañós M; Department of Otorhinolaryngology, Hospital Universitari Bellvitge, L'Hospitalet de Llobregat, Barcelona, Spain.; Program of Molecular Mechanisms and Experimental Therapy in Oncology, Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, Barcelona, Spain.; University of Barcelona, Barcelona, Spain., Alemany L; Cancer Epidemiology Research Program, Catalan Institute of Oncology (ICO) - L'Hospitalet de Llobregat, Barcelona, Spain.; Epidemiology, Public Health, Cancer Prevention and Palliative Care Program, IDIBELL, L'Hospitalet de Llobregat, Barcelona, Spain.; Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), Instituto de Salud Carlos III, Madrid, Spain., Mena M; Cancer Epidemiology Research Program, Catalan Institute of Oncology (ICO) - L'Hospitalet de Llobregat, Barcelona, Spain.; Epidemiology, Public Health, Cancer Prevention and Palliative Care Program, IDIBELL, L'Hospitalet de Llobregat, Barcelona, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Instituto de Salud Carlos III, Madrid, Spain., Gonzalez X; Department of Otorhinolaryngology, Hospital Universitari Bellvitge, L'Hospitalet de Llobregat, Barcelona, Spain.; Program of Molecular Mechanisms and Experimental Therapy in Oncology, Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, Barcelona, Spain.
Publikováno v:
Head and neck pathology [Head Neck Pathol] 2020 Sep; Vol. 14 (3), pp. 758-767. Date of Electronic Publication: 2020 Jan 08.
Autor:
Zhang, Lifeng1,2 (AUTHOR), Luo, Shihua3,4 (AUTHOR), Li, Wenbin1,5,6 (AUTHOR), Su, Wanting1,5 (AUTHOR), Chen, Siting1,5,6 (AUTHOR), Liu, Chunchen1,5 (AUTHOR), Pan, Weilun1,5 (AUTHOR), Situ, Bo1,5 (AUTHOR), Zheng, Lei1,5 (AUTHOR) nfyyzhenglei@smu.edu.cn, Li, Ling2,7 (AUTHOR) liling@smu.edu.cn, Yan, Xiaohui1,5,6 (AUTHOR) gzyanxh@126.com, Zhang, Ye1,5 (AUTHOR) zhangye232@i.smu.edu.cn
Publikováno v:
Journal of Nanobiotechnology. 10/5/202, p1-13. 13p.